Feb 28, 2023 Cellectar Biosciences Reports Complete Response in a Relapsed/Refractory CNS Lymphoma Patient Learn More
Feb 15, 2023 Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical Learn More
Nov 21, 2022 Cellectar Biosciences Announces Presentation of Data on CLR 12120 Series of Targeted Alpha-Emitting Therapies at the 13th Annual World ADC Conference Learn More